Suppr超能文献

评估补充克罗恩病活动指数的适当实验室检测指标。

Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.

作者信息

Andre C, Descos L, Landais P, Fermanian J

出版信息

Gut. 1981 Jul;22(7):571-4. doi: 10.1136/gut.22.7.571.

Abstract

The ability of 11 laboratory parameters to reflect the degree of activity of Crohn's disease, using a clinical index as reference point was compared by means of multiple stepwise regression analysis. Activity was best defined in decreasing order by orosomucoid, sedimentation rate, C reactive protein, alpha-1-antitrypsin, albumin, haematocrit, IgM, circulating immune complexes, serum iron, IgG, and IgA. The haematocrit, the only laboratory measurement in the Crohn's disease activity index developed by the National Cooperative Study Group in the USA, is less discriminant than acute phase reactants. Only three parameters-namely, orosomucoid, sedimentation rate, and C reactive protein-have a significant weight and should be complementary to a simple clinical index.

摘要

通过多元逐步回归分析,比较了11项实验室指标以临床指标为参考点反映克罗恩病活动程度的能力。按活性由高到低的顺序,活性最佳的定义指标依次为:血清类粘蛋白、血沉、C反应蛋白、α1-抗胰蛋白酶、白蛋白、血细胞比容、IgM、循环免疫复合物、血清铁、IgG和IgA。血细胞比容是美国国家合作研究组制定的克罗恩病活动指数中唯一的实验室测量指标,其鉴别能力不如急性期反应物。只有三项指标,即血清类粘蛋白、血沉和C反应蛋白,具有显著权重,应作为简单临床指标的补充。

相似文献

3
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
Gastroenterology. 1985 Jul;89(1):13-8. doi: 10.1016/0016-5085(85)90739-5.
6
7
Circulating immune complexes and disease activity in Crohn's disease.
Gut. 1978 Jul;19(7):611-7. doi: 10.1136/gut.19.7.611.
9
10
Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis.
J Pediatr Gastroenterol Nutr. 1986 Jan;5(1):93-6. doi: 10.1097/00005176-198601000-00017.

引用本文的文献

1
Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease.
JGH Open. 2019 Oct 6;4(3):410-416. doi: 10.1002/jgh3.12266. eCollection 2020 Jun.
2
Serum Resolvin E1 Levels and Its Relationship with Disease Activity in Ulcerative Colitis.
Gastroenterol Res Pract. 2019 Feb 14;2019:6258327. doi: 10.1155/2019/6258327. eCollection 2019.
3
The Role of Laboratory Tests in Crohn's Disease.
Clin Med Insights Gastroenterol. 2016 Aug 18;9:51-62. doi: 10.4137/CGast.S38203. eCollection 2016.
4
Laboratory markers in ulcerative colitis: Current insights and future advances.
World J Gastrointest Pathophysiol. 2015 Feb 15;6(1):13-22. doi: 10.4291/wjgp.v6.i1.13.
5
A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging.
PLoS One. 2014 Aug 4;9(8):e102426. doi: 10.1371/journal.pone.0102426. eCollection 2014.
6
When Crohn's disease is in remission, more patients complete capsule endoscopy study but less lesions are identified.
Saudi J Gastroenterol. 2013 Mar-Apr;19(2):63-8. doi: 10.4103/1319-3767.108468.
7
Current advantages in the application of proteomics in inflammatory bowel disease.
Dig Dis Sci. 2012 Nov;57(11):2755-64. doi: 10.1007/s10620-012-2291-4. Epub 2012 Jun 28.
8
Biomarkers in inflammatory bowel disease: current practices and recent advances.
Transl Res. 2012 Apr;159(4):313-25. doi: 10.1016/j.trsl.2012.01.001. Epub 2012 Feb 1.
9
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Gut. 2006 Mar;55(3):426-31. doi: 10.1136/gut.2005.069476.
10
Influence of treatment on morphological features of mucosal inflammation.
Gut. 2002 May;50 Suppl 3(Suppl 3):III37-42. doi: 10.1136/gut.50.suppl_3.iii37.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验